To: | Neurimmune Holding AG (jhousey@symbus.com) |
Subject: | U.S. TRADEMARK APPLICATION NO. 85656493 - REVERSE TRANSLATIONAL MEDICINE - N/A |
Sent: | 2/5/2014 11:30:27 AM |
Sent As: | ECOM111@USPTO.GOV |
Attachments: |
UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
U.S. APPLICATION SERIAL NO. 85656493
MARK: REVERSE TRANSLATIONAL MEDICINE
|
|
CORRESPONDENT ADDRESS: |
GENERAL TRADEMARK INFORMATION: http://www.gov.uspto.report/trademarks/index.jsp
|
APPLICANT: Neurimmune Holding AG
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO: CORRESPONDENT E-MAIL ADDRESS: |
|
EXAMINER’S AMENDMENT
ISSUE/MAILING DATE: 2/5/2014
DATABASE SEARCH: The trademark examining attorney has searched the USPTO’s database of registered and pending marks and has found no conflicting marks that would bar registration under Trademark Act Section 2(d). TMEP §704.02; see 15 U.S.C. §1052(d).
APPLICATION HAS BEEN AMENDED: In accordance with the authorization granted by the applicant’s attorney on February 4, 2014, the trademark examining attorney has amended the application as indicated below. Please advise the undersigned immediately of any objections. Otherwise, no response is necessary. TMEP §707. Any amendments to the identification of goods and/or services may clarify or limit the goods and/or services, but may not add to or broaden the scope of the goods and/or services. 37 C.F.R. §2.71(a); see TMEP §§1402.06 et seq.
The identification of goods is amended to read as follows:
Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; Dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely dietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely low calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases in International Class 5.
TMEP §1402.01(e).
/Dawn Feldman Lehker/
Trademark Examining Attorney
Law Office 111
U.S. Patent and Trademark Office
(571)272-9381
dawn.feldman-lehker@uspto.gov
PERIODICALLY CHECK THE STATUS OF THE APPLICATION: To ensure that applicant does not miss crucial deadlines or official notices, check the status of the application every three to four months using the Trademark Status and Document Retrieval (TSDR) system at http://tsdr.gov.uspto.report/. Please keep a copy of the TSDR status screen. If the status shows no change for more than six months, contact the Trademark Assistance Center by e-mail at TrademarkAssistanceCenter@uspto.gov or call 1-800-786-9199. For more information on checking status, see http://www.gov.uspto.report/trademarks/process/status/.
TO UPDATE CORRESPONDENCE/E-MAIL ADDRESS: Use the Trademark Electronic Application System (TEAS) form at http://www.gov.uspto.report/trademarks/teas/correspondence.jsp.